Literature DB >> 16464762

Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.

Kaye L Johnston1, John P Farnen, Brian R Manske, Ronald S Go.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16464762

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  3 in total

1.  Optimizing the interval between G-CSF therapy and F-18 FDG PET imaging in children and young adults receiving chemotherapy for sarcoma.

Authors:  Andrew T Trout; Susan E Sharp; Brian K Turpin; Bin Zhang; Michael J Gelfand
Journal:  Pediatr Radiol       Date:  2015-02-03

2.  False-positive diagnosis of disease progression by magnetic resonance imaging for response assessment in prostate cancer with bone metastases: A case report and review of the pitfalls of images in the literature.

Authors:  Yi-Shan Yu; Wan-Hu Li; Ming-Huan Li; Xue Meng; L I Kong; Jin-Ming Yu
Journal:  Oncol Lett       Date:  2015-09-25       Impact factor: 2.967

3.  Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.

Authors:  Chengzhong Fan; Miguel Hernandez-Pampaloni; Mohamed Houseni; Wichana Chamroonrat; Sandip Basu; Rakesh Kumar; Simin Dadparvar; Drew A Torigian; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2007 Sep-Oct       Impact factor: 3.484

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.